Overview

This trial is active, not recruiting.

Condition hip arthritis
Sponsor Aesculap AG
Start date September 2014
End date November 2015
Trial size 100 participants
Trial identifier NCT02188095, AAG-O-H-1401

Summary

Clinical and radiological 3 year results of Excia T® Hip Stem

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm

Primary Outcomes

Measure
Survival Rate of the Implant
time frame: 10 years

Secondary Outcomes

Measure
Hip disability and Osteoarthritis Outcome Score (HOOS)
time frame: 10 years
Harris Hip Score (HHS)
time frame: 10 years
Pain
time frame: 10 years
Shaftposition ap and lateral
time frame: 10 years
Stress Shielding
time frame: 10 years
Hypertrophies
time frame: 10 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patient gave written informed consent - age ≥ 18 years Exclusion Criteria: - pregnancy

Additional Information

Official title Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
Principal investigator Peter Aldinger, Prof. Dr.
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Aesculap AG.